Leaflet DHC CONTINUS 120mg prolonged-release tablets

Indicated for: pain; cough

Route of administration: oral

Substance: dihydrocodeine (analgesic and antipyretic)

ATC: N02AA08 (Nervous system | Opioids | Natural opium alkaloids)

Precautions:
Driving impairment
Driving impairment

This medicine may affect your ability to drive or use machines.

Dizziness / vertigo
Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Dependence / abuse
Dependence / abuse

This medicine may cause dependence or be misused.

Respiratory depression
Respiratory depression

May slow breathing, especially with alcohol or sedatives.

Avoid alcohol
Avoid alcohol

Avoid alcohol during treatment.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Elderly warning
Elderly warning

Older people may have an increased risk of side effects.

Withdrawal / do not stop abruptly
Withdrawal / do not stop abruptly

Do not stop treatment abruptly without medical advice.

Drowsiness / sedation
Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Dihydrocodeine is an opioid medication used to treat moderate to severe pain, especially when other analgesics, such as paracetamol or nonsteroidal anti-inflammatory drugs (NSAIDs), are insufficient. It can also be used to treat severe cough due to its antitussive effect.

Dihydrocodeine works by binding to opioid receptors in the central nervous system, reducing the perception of pain and the response to it. It is available in tablet, capsule, or oral solution form, and its analgesic effect typically lasts between 4 and 6 hours.

Side effects may include drowsiness, dizziness, constipation, nausea, dry mouth, or, in rare cases, allergic reactions. Long-term use can lead to physical and psychological dependence, so the medication should be taken as prescribed by a doctor. Patients should avoid alcohol consumption or driving while on this medication, as dihydrocodeine can impair alertness.

General data about DHC CONTINUS 120mg

  • Substance: dihydrocodeine
  • Date of latest medicines list: 01-06-2026
  • Product code: W70075001
  • Concentration: 120mg
  • Pharmaceutical form: prolonged-release tablets
  • Quantity: 56
  • Product type: Original
  • Price: 126.21 RON
  • Prescription status: TAB3 - Medicines dispensed with a special medical prescription for psychotropic substances, green in color.

Marketing authorisation

  • Manufacturer: MUNDIPHARMA GMBH - GERMANIA
  • Holder: ENNOGEN HEALTHCARE (EUROPE) LIMITED - IRLANDA
  • Number: 4898/2012/01
  • Shelf life: 3 years

Concentrations available for dihydrocodeine

  • 120mg
  • 60mg
  • 90mg

Compensation lists for DHC CONTINUS 120mg Ennogen Healthcare

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

126.21 RON

50.07 RON

76.14 RON

G10 (C1) - Leukemias, lymphomas and bone marrow aplasia, tumors

Price

Copayment

Patient

126.21 RON

126.21 RON

0.00 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price

Copayment

Patient

126.21 RON

126.21 RON

0.00 RON